Previous studies have reported that NfL levels were significantly elevated in patients with PIGD with worse cognition outcomes and were modestly correlated with MDS-UPDRS III scores, indicating that there was a relationship between NfL and disease severity and progression in PIGD-PD (Ng et al., 2020; Ye et al., 2021). This evidence concerns the gene NEFL and Parkinson disease.